Measuring abdominal (intraperitoneal) pressure during peritoneal dialysis in children
Official title: Intraperitoneal Pressure Measurements Survey in Pediatric Centers
Run by University Hospital, Strasbourg, France · NCT07339709 · Data updated 2026-11-12
This project will see how healthcare professionals in European pediatric dialysis centers measure intraperitoneal pressure (IPP) in children on peritoneal dialysis.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | July 16, 2025 |
| Main results expected | July 2026 |
| Study ends | July 16, 2026 |
| Registry record updated | January 14, 2026 |
| Trial ID | NCT07339709 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
This project enrolls healthcare professionals rather than patients, so children on peritoneal dialysis are not directly enrolled as participants.
✕Probably not a fit
Children who are not treated with peritoneal dialysis or who receive care outside participating European centers will not be enrolled and will not directly benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational survey asking healthcare professionals in European pediatric dialysis centers about their use and measurement of intraperitoneal pressure (IPP) in children on peritoneal dialysis. Respondents will report measurement techniques, frequency, thresholds used, and how IPP results influence dialysis prescriptions. The study collects descriptive data only and does not change patient care. The aim is to document current practice variation and identify gaps that could guide future standardization and research.
Why it matters
Potential benefit: If successful, the results could help standardize IPP measurement and lead to more consistent dialysis prescriptions and potentially fewer complications for children on peritoneal dialysis.
How similar studies have gone: Adult observational studies have linked higher IPP (around 13–14 cmH2O) to worse outcomes, but pediatric evidence is limited and this survey is relatively novel for pediatric centers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Healthcare professional working in a European dialysis center Exclusion Criteria: \- Refusal to participate in the study.
Where it's running
-
Service de pédiatrie 1 - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Ariane ZALOSZYC, MD, PhD
- Email: ariane.zaloszyc@chru-strasbourg.fr
- Phone: 33 3 88 12 77 42
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Menin inhibitors in pediatric relapsed or refractory acute leukemia
This study looks at kids with relapsed or treatment-resistant acute leukemia who have specific genetic changes and are treated with menin inhibitors to see how they fare.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Toxicity of intensive first-line treatment for adult Burkitt lymphoma
This study looks back at adult Burkitt lymphoma patients treated with very aggressive first-line chemotherapy to see how toxic the treatment is and what their long-term outcomes were.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.